GlaxoSmithKline confirms presence of material from PCV-1 virus in Rotarix

Published: 2010-03-26 06:59:00

Updated: 2010-03-26 06:59:00

GlaxoSmithKline (GSK) confirmed on March 22 that it has notified the Korea Food and Drug Administration of the presence of material from a virus called PCV-1 in its oral rotavirus vaccine, Rotarix.

PCV-1 does not multiply in humans and is not known to cause illness in humans. It is found in e...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK